DCLAK11 treatment induces apoptosis in non‐small cell lung cancer cells by inhibiting the mitochondrial apoptosis pathway
Abstract Objective DCLAK11 is a novel small molecule tyrosine kinase inhibitor with remarkable effects on cell proliferation and apoptosis in non‐small cell lung cancer cells. Therefore, it is necessary to determine the molecular mechanisms of action of this compound. In this study, we investigated...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-09-01
|
Series: | Precision Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/pro6.1073 |